window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Genomics and sequencing

  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    New England Biolabs launches Monarch Mag Cell-free DNA extraction kit for scalable cfDNA isolation

    New England Biolabs has launched the Monarch Mag Cell-free DNA [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Insitro completes first AI-enabled human genetics study of brown adipose tissue, identifies differentiated obesity targets

    insitro has completed what it says is the first population-scale [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform

    SPT Labtech has announced the availability of validated automated workflows [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    PacBio HiFi adopted to study sudden unexplained death in childhood and advance precision therapies for rare diseases

    PacBio is supporting two research initiatives that use its HiFi [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Flagship Pioneering signs new agreements with ProFound Therapeutics and Quotient Therapeutics with GSK collaboration

    Flagship Pioneering has announced that ProFound Therapeutics and Quotient Therapeutics [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    Sheba, Mount Sinai and NVIDIA launch AI collaboration to decode unexplored regions of the human genome

    ARC Innovation at Sheba Medical Center and the Icahn School [...]

    May 5, 2026
  • Drug Discovery & Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Therapeutic Areas

    Ochre Bio and GSK complete research phase with large-scale human liver genomics datasets

    Ochre Bio has completed the research phase of its collaboration [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Mursla Bio partners with global pharma to advance biomarker-guided precision medicine in MASH

    Mursla Bio has announced a collaboration with a leading global [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Atomic ‘Hook’ in motor protein unlocks neuron cargo delivery secrets

    A team from the University of Tokyo and Juntendo University [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing

    Nucleome Therapeutics and Oxford University reveal genome structure at base pair resolution

    Nucleome Therapeutics and Oxford University scientists have mapped the 3D [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Atsena advances gene therapy ATSN-201 into Phase 3 trial for inherited blindness
    Categories: Advanced Therapies, Clinical & Regulatory, Genomics and sequencing, Therapeutic Areas
  • Pierre Fabre wins EU approval for first-line BRAFTOVI regimen in BRAF-mutant colorectal cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • African health leaders launch Imara framework to strengthen sickle cell disease care across Africa
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top